← FDA DRUG APPROVALS

FDA ANDA · ANDA086988

METHOCARBAMOL

Sponsor: PRINSTON INC

APPLICATION
ANDA086988
TYPE
ANDA
ORIGINAL APPROVAL
1979-10-29
LATEST ACTION
2025-04-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METHOCARBAMOLPrescription
METHOCARBAMOL 500MG · TABLET · ORAL
METHOCARBAMOLPrescription
METHOCARBAMOL 750MG · TABLET · ORAL

Approval history

2025-04-08Labeling · Supplement 15 · standardAP
2012-09-28Manufacturing (CMC) · Supplement 9AP
1988-11-08Manufacturing (CMC) · Supplement 7AP
1988-11-08Manufacturing (CMC) · Supplement 5AP
1988-11-08Manufacturing (CMC) · Supplement 6AP
1986-06-19Manufacturing (CMC) · Supplement 3AP
1986-06-09Manufacturing (CMC) · Supplement 4AP
1979-10-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →